DETERMINATION OF KINETIC-PARAMETERS OF PLASMINOGEN ACTIVATION (PG) BY TISSUE-TYPE ACTIVATOR (TPA)

被引:0
|
作者
LEBONNIEC, B [1 ]
ANGLESCANO, E [1 ]
机构
[1] HOP COCHIN,INSERM,U152,F-75674 PARIS 14,FRANCE
来源
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 1986年 / 28卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:122 / 122
页数:1
相关论文
共 50 条
  • [1] THE INFLUENCE OF FIBRIN(OGEN) FRAGMENTS ON THE KINETIC-PARAMETERS OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR-MEDIATED ACTIVATION OF DIFFERENT FORMS OF PLASMINOGEN
    NIEUWENHUIZEN, W
    VOSKUILEN, M
    VERMOND, A
    HOEGEEDENOBEL, B
    TRAAS, DW
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 174 (01): : 163 - 169
  • [3] Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
    Chevilley, Arnaud
    Lesept, Flavie
    Lenoir, Sophie
    Ali, Carine
    Parcq, Jerome
    Vivien, Denis
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [4] KINETIC EVALUATION OF THE EFFECT OF A FRAGMENT OF FIBRINOGEN ON THE ACTIVATION OF PLASMINOGEN BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    STEINER, SA
    MCKEE, PA
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 268 - 268
  • [5] TISSUE-TYPE PLASMINOGEN ACTIVATOR (TPA)-INDUCED DIFFUSE ALVEOLAR HEMORRHAGE
    Wiggins, Brandon T.
    Wieckowska, Joanna
    Govan, Brandon
    Khorfan, Omar
    CHEST, 2022, 162 (04) : 1175A - 1175A
  • [6] Tissue-Type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance
    M. Daniela Corte
    Paula Vérez
    Juan Carlos Rodríguez
    Antonio Roibás
    M. Luz Domínguez
    M. Luz Lamelas
    Julio Vázquez
    José L García Muñiz
    M. Teresa Allende
    Luis Ovidio González
    Antonio Fueyo
    Francisco Vizoso
    Breast Cancer Research and Treatment, 2005, 90 : 33 - 40
  • [7] MECHANISMS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) CLEARANCE BY THE LIVER
    OTTER, M
    KUIPER, J
    VANBERKEL, TJC
    RIJKEN, DC
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 : 431 - 442
  • [8] Tissue-type plasminogen activator (tPA) in breast cancer:: relationship with clinicopathological parameters and prognostic significance
    Corte, MD
    Vérez, P
    Rodríguez, JC
    Roibás, A
    Domínguez, ML
    Lamelas, ML
    Vázquez, J
    Muñiz, JLG
    Allende, MT
    González, LO
    Fueyo, A
    Vizoso, F
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (01) : 33 - 40
  • [9] The story of an exceptional serine protease, tissue-type plasminogen activator (tPA)
    Hebert, M.
    Lesept, F.
    Vivien, D.
    Macrez, R.
    REVUE NEUROLOGIQUE, 2016, 172 (03) : 186 - 197
  • [10] MECHANISMS OF ACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    FISCHER, B
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (05): : 625 - 632